Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Takemasa Matsumoto, Masaki Fujita, Ryousuke Hirano, Tomoya Sasaki & Kentaro Watanabe. (2019) Risk factors for pneumocystis pneumonia onset in HIV-negative patients treated with high-dose systemic corticosteroids. Infectious Diseases 51:4, pages 305-307.
Read now
Read now
Michi Tanaka, Ryoko Sakai, Ryuji Koike, Yukiko Komano, Toshihiro Nanki, Fumikazu Sakai, Haruhito Sugiyama, Hidekazu Matsushima, Toshihisa Kojima, Shuji Ohta, Yoji Ishibe, Takuya Sawabe, Yasuhiro Ota, Kazuhisa Ohishi, Hajime Miyazato, Yoshinori Nonomura, Kazuyoshi Saito, Yoshiya Tanaka, Hayato Nagasawa, Tsutomu Takeuchi, Ayako Nakajima, Hideo Ohtsubo, Makoto Onishi, Yoshinori Goto, Hiroaki Dobashi, Nobuyuki Miyasaka & Masayoshi Harigai. (2012) Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors. Modern Rheumatology 22:6, pages 849-858.
Read now
Read now
A. K. Tyagi, B. R. Mirdha, K. Luthra, R. Guleria, A. Mohan, U. B. Singh, J. C. Samantaray, L. Dar, V. K. Iyer & V. Sreenivas. (2011) Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: a tertiary care reference health centre study. Medical Mycology 49:2, pages 167-171.
Read now
Read now
Articles from other publishers (32)
Anji Xiong, Wenxuan Luo, Xiaoyu Tang, Yuzi Cao, Qilang Xiang, Ruiting Deng & Shiquan Shuai. (2023) Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis. Seminars in Arthritis and Rheumatism 63, pages 152257.
Crossref
Crossref
Kohei Miyake, Tetsuji Kawamura, Yasuharu Nakahara & Shin Sasaki. (2023) A single-center, person-month-based analysis of the risk of developing Pneumocystis pneumonia (PCP) in immunosuppressed non-HIV patients: Preventive effects of trimethoprim-sulfamethoxazole. Journal of Infection and Chemotherapy 29:12, pages 1097-1102.
Crossref
Crossref
Ting Xue, Xiaomei Kong & Liang Ma. (2023) Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection. Journal of Fungi 9:8, pages 812.
Crossref
Crossref
Shunsuke Mori, Yukitaka Ueki, Tomoya Miyamura, Koji Ishii, Toshihiko Hidaka, Tamami Yoshitama, Kazuyoshi Nakamura & Yasuo Suenaga. (2023)
Outcomes and risk factors for mortality in
Pneumocystis
pneumonia patients with rheumatoid arthritis: A multicentre retrospective cohort study
. Modern Rheumatology 33:4, pages 723-731.
Crossref
Crossref
Marjorie Bateman, Rita Oladele & Jay K Kolls. (2020) Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches. Medical Mycology 58:8, pages 1015-1028.
Crossref
Crossref
Ariel D. Szvalb, Alexandre E. Malek, Ying Jiang, Micah M. Bhatti, Sebastian Wurster & Dimitrios P. Kontoyiannis. (2020) Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. Journal of Infection 81:3, pages 443-451.
Crossref
Crossref
Lorenzo Cereser, Anna Dallorto, Anna Candoni, Stefano Volpetti, Elda Righi, Chiara Zuiani & Rossano Girometti. (2019) Pneumocystis jirovecii pneumonia at chest High-resolution Computed Tomography (HRCT) in non-HIV immunocompromised patients: Spectrum of findings and mimickers. European Journal of Radiology 116, pages 116-127.
Crossref
Crossref
Takahiro Kageyama, Shunsuke Furuta, Kei Ikeda, Shin-ichiro Kagami, Daisuke Kashiwakuma, Takao Sugiyama, Takeshi Umibe, Norihiko Watanabe, Mieko Yamagata & Hiroshi Nakajima. (2019) Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases. PLOS ONE 14:3, pages e0214324.
Crossref
Crossref
María Agustina Dal Molín-Veglia, Francisca Sánchez-Martínez, Antonio Fernando Fernández-Alarza & Marisol Domínguez-Álvarez. (2018) Micobacteriosis pulmonar en un paciente en tratamiento crónico con metotrexato. Archivos de Bronconeumología 54:4, pages 225-226.
Crossref
Crossref
M.-A. Cornetto & A. Bergeron. (2018) Cas clinique n° 6 : Infection pulmonaire au cours d’une maladie de système. Revue des Maladies Respiratoires Actualités 10:1, pages 46-52.
Crossref
Crossref
Yutaka Tsuchiya & Hironori Sagara. 2018. Lung Disease Associated with Rheumatoid Arthritis. Lung Disease Associated with Rheumatoid Arthritis
151
164
.
Noboru Takayanagi,. (2015) Biological agents and respiratory infections: Causative mechanisms and practice management. Respiratory Investigation 53:5, pages 185-200.
Crossref
Crossref
Andrew J. Teichtahl, Kathleen Morrisroe, Sabina Ciciriello, Ian Jennens, Susan Tadros & Ian Wicks. (2015) Pneumocystis jirovecci pneumonia in connective tissue diseases: Comparison with other immunocompromised patients. Seminars in Arthritis and Rheumatism 45:1, pages 86-90.
Crossref
Crossref
Sandra Chartrand & Aryeh Fischer. (2015) Management of Connective Tissue Disease–associated Interstitial Lung Disease. Rheumatic Disease Clinics of North America 41:2, pages 279-294.
Crossref
Crossref
Norihiko GotoKenta FutamuraManabu OkadaTakayuki YamamotoMakoto TsujitaTakahisa HiramitsuShunji NarumiYoshihiko Watarai. (2015)
Management of
Pneumocystis jirovecii
Pneumonia in Kidney Transplantation to Prevent Further Outbreak
. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23317.
Crossref
Crossref
Shunsuke MoriMineharu Sugimoto. (2015)
Pneumocystis Jirovecii
Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23286.
Crossref
Crossref
Carina A. Ruano, Rita N. Lucas, Cecília I. Leal, João Lourenço, Sofia Pinheiro, Otília Fernandes & Luísa Figueiredo. (2015) Thoracic Manifestations of Connective Tissue Diseases. Current Problems in Diagnostic Radiology 44:1, pages 47-59.
Crossref
Crossref
Yongfeng Zhang & Yi Zheng. (2014) Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases. Rheumatology International 34:12, pages 1765-1771.
Crossref
Crossref
Tatsuhiro YAMAMOTO, Tomoko HASUNUMA, Kenji TAKAGI, Kimiko AKIMOTO, Kotaro SHIKANO, Makoto KABURAKI, Sei MURAOKA, Kanako KITAHARA, Nahoko TANAKA, Kaichi KANEKO, Yoshie KUSUNOKI, Hirahito ENDO & Shinichi KAWAI. (2014) A Feasibility Study Assessing Tolerability of Daily versus Twice Weekly Trimethoprim-Sulfamethoxazole Regimen for Prophylaxis against Pneumocystis Pneumonia in Patients with Systemic Autoimmune Diseases on Glucocorticoid Therapy. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 45:3, pages 89-92.
Crossref
Crossref
D.E. Karageorgopoulos, J.-M. Qu, I.P. Korbila, Y.-G. Zhu, V.A. Vasileiou & M.E. Falagas. (2013) Accuracy of β -D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clinical Microbiology and Infection 19:1, pages 39-49.
Crossref
Crossref
Y. Matsumura, Y. Ito, Y. Iinuma, K. Yasuma, M. Yamamoto, A. Matsushima, M. Nagao, S. Takakura & S. Ichiyama. (2012) Quantitative real-time PCR and the (1 → 3)-β-d-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clinical Microbiology and Infection 18:6, pages 591-597.
Crossref
Crossref
Alison Morris & Karen A. Norris. (2012) Colonization by Pneumocystis jirovecii and Its Role in Disease. Clinical Microbiology Reviews 25:2, pages 297-317.
Crossref
Crossref
Ria Gripaldo & Michael L. Lippmann. (2012) Pneumocystis Pneumonia in HIV-Negative Patients. Clinical Pulmonary Medicine 19:1, pages 5-13.
Crossref
Crossref
Yasufumi Matsumura, Yuichiro Shindo, Yoshitsugu Iinuma, Masaki Yamamoto, Michinori Shirano, Aki Matsushima, Miki Nagao, Yutaka Ito, Shunji Takakura, Yoshinori Hasegawa & Satoshi Ichiyama. (2011) Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infectious Diseases 11:1.
Crossref
Crossref
J. Held, M.S. Koch, U. Reischl, T. Danner & A. Serr. (2011) Serum (1 → 3)-β-d-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value. Clinical Microbiology and Infection 17:4, pages 595-602.
Crossref
Crossref
Hideto Kameda, Hitoshi Tokuda, Fumikazu Sakai, Takeshi Johkoh, Shunsuke Mori, Yuji Yoshida, Noboru Takayanagi, Hirofumi Taki, Yoshinori Hasegawa, Kazuhiro Hatta, Hisashi Yamanaka, Makoto Dohi, Shu Hashimoto, Hidehiro Yamada, Shinichi Kawai, Tsutomu Takeuchi, Kazuhiro Tateda & Hajime Goto. (2011) Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of <i>Pneumocystis</i> Pneumonia in Japan Revealed by a Multicenter Study. Internal Medicine 50:4, pages 305-313.
Crossref
Crossref
Mónica Bogas, Pedro Machado, Ana Filipa Mourão, Lúcia Costa, Maria José Santos, João Eurico Fonseca, José António P. Silva & Helena Canhão. (2010) Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review. Clinical Rheumatology 29:6, pages 629-635.
Crossref
Crossref
Yoko Aoki, Masahiro Iwamoto, Yasuyuki Kamata, Takao Nagashima, Taku Yoshio, Hitoaki Okazaki & Seiji Minota. (2009) Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases. Rheumatology International 29:11, pages 1327-1330.
Crossref
Crossref
Élie Azoulay, Anne Bergeron, Sylvie Chevret, Nicolas Bele, Benoît Schlemmer & Jean Menotti. (2009) Polymerase Chain Reaction for Diagnosing Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients With Pulmonary Infiltrates. Chest 135:3, pages 655-661.
Crossref
Crossref
Shunsuke Mori, Isamu Cho, Hidenori Ichiyasu & Mineharu Sugimoto. (2008) Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Modern Rheumatology 18:3, pages 240-246.
Crossref
Crossref
L. Beth Gadkowski & Jason E. Stout. (2008) Cavitary Pulmonary Disease. Clinical Microbiology Reviews 21:2, pages 305-333.
Crossref
Crossref
Vamsidhar Velcheti & Ramaswamy Govindan. (2007) Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimen. Lung Cancer 57:2, pages 240-242.
Crossref
Crossref